home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

VEGF gene therapy can imporve heart function

  November, 16 2001 1:10
your information resource in human molecular genetics
VEGF gene therapy eases pain, improves heart function

ANAHEIM, Calif., Nov. 12 – Injecting a growth factor gene directly into the heart is safe and appears highly effective in treating advanced coronary heart disease, two research teams report today at the American Heart Association’s Scientific Sessions 2001 conference. Both teams described follow-up results of experimental treatments in which each used a slightly different variation of the gene for vascular endothelial growth factor (VEGF). This naturally occurring protein plays a key role in initiating the growth of new blood vessels. One team reported two-year results with VEGF-1, the other reported a one-year follow-up with VEGF-2.

Carole Bullock
American Heart Association

Message posted by: Wouter Kalle

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.